TITLE: Safety Standards for the Compounding and Dispensing of Compounded Drug Products

WHEREAS, the compounding of drug products for patients may include materials that are deemed hazardous by the appropriate state or federal agency or active pharmaceutical ingredients (APIs) that require black box warnings in their labeling; and

WHEREAS, the handling of those types of materials or APIs in the preparation of such compounded drug products or the dispensing of those drug products to the patient or caregiver could endanger the health of the pharmacist or technician who compounded the drug product, and the patient or caregiver who received the compounded drug product;

THEREFORE BE IT RESOLVED that NABP encourage United States Pharmacopeial Convention (USP) and/or other stakeholders to develop educational information concerning USP Chapter <800> and the appropriate handling of these types of materials to be provided to the patient or caregiver.

(Resolution passed at the 114th Annual Meeting in Denver, CO.)